Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers
Conclusions:
Our data further strengthens the role for CREB3L1 as a metastasis suppressor in breast cancer and demonstrates that epigenetic silencing is a major regulator of the loss of CREB3L1 expression. We also highlight that CREB3L1 expression is frequently altered in many cancer types suggesting that it could have a broader role in cancer progression and metastasis.
Source: Breast Cancer Research - Category: Cancer & Oncology Authors: Alison WardPaul MellorShari SmithStephanie KendallNatasha JustFrederick VizeacoumarSabuj SarkerZoe PhillipsRiaz AlviAnurag SaxenaFranco VizeacoumarSvein CarlsenDeborah Anderson Source Type: research
More News: Bladder Cancer | Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | HER2 | Study